actinium-225/bismuth-213 radioisotope program (NorthStar Medical Technologies)

N/A

Report date: 2025/01/26 18:43:30

Base Information

Drug Nameactinium-225/bismuth-213 radioisotope program (NorthStar Medical Technologies)
Drug Alias Nameactinium-225/bismuth-213 radioisotope program (NorthStar Medical Technologies)high energy alpha emitting radioisotopes (NorthStar Medical Technologies)Ac-225/Bi-213 radioisotopes (NorthStar Medical Technologies)targeted alpha-particle therapy (NorthStar Medical Technologies)
ClassificationBiologicsRadiation-emitting products
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAtherosclerosisLeukemia, Myeloid, AcuteHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNorthStar Medical Technologies LLC
China Registration ClassN/A

Develop Information

Active CompaniesNorthStar Medical Technologies LLC
Inactive CompaniesN/A
Active IndicationsAtherosclerosisLeukemia, Myeloid, AcuteHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A